Therapeutic hyperinsulinemia, either absolute or relative, as a result of exogenous insulin during insulin therapy or following insulin secretagogue therapy, is the initiating cause of hypoglycemia in diabetes. The gene discussed is INS; the disease is hyperinsulinism.